A New CAR‑T Strategy for Bone Cancer That May Help Metastatic Prostate Disease

Scientists have developed a promising new CAR‑T cell therapy for osteosarcoma, the most common bone cancer in children, adolescents, and young adults, and the work carries a cautiously optimistic signal for other solid tumors, including metastatic prostate cancer. In a preclinical study, researchers at Case Western Reserve University and University Hospitals engineered T cells to […]

Smart Antibody Medicines: How the ALCO5 Platform Could Upgrade Targeted Cancer Therapy

ALCO5 is a new way of building “smart” cancer drugs that combine an antibody with a powerful medicine in a single, targeted package. The aim is to hit cancer cells much harder while sparing as much healthy tissue as possible, and to do this with drug types that previously could not be used in these […]

Logic-gated DARPins, a Promising Advancement in Immune Therapy for Solid Tumors

Logic-gated DARPins are a promising new tool in cancer treatment that could make immunotherapy safer and more effective for hard-to-treat solid tumors. They work by only turning on immune cells called T cells when two specific markers are found together on cancer cells, preventing dangerous overactivation in healthy parts of the body.​ What makes them […]

The Promise of In Vivo CAR T Cell Therapies